[{"id":"8b42396d-b532-43cc-a1a6-b2779c03e396","acronym":"","url":"https://clinicaltrials.gov/study/NCT03495609","created_at":"2021-01-18T17:12:44.009Z","updated_at":"2024-07-02T16:35:37.828Z","phase":"Phase 4","brief_title":"Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers","source_id_and_acronym":"NCT03495609","lead_sponsor":"University Hospital, Ghent","biomarkers":" BRCA1 • BRCA2","pipe":"","alterations":" ","tags":["BRCA1 • BRCA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Ovidrel (choriogonadotropin alfa)"],"overall_status":"Completed","enrollment":" Enrollment 33","initiation":"Initiation: 02/17/2016","start_date":" 02/17/2016","primary_txt":" Primary completion: 12/18/2018","primary_completion_date":" 12/18/2018","study_txt":" Completion: 12/18/2018","study_completion_date":" 12/18/2018","last_update_posted":"2023-09-07"}]